Haleon PLC 6-K Filing

Filing Documents

• a6788j.htm (6-K) — 20KB
• a6788j000.jpg (GRAPHIC) — 3KB
• 0001654954-25-013537.txt ( ) — 26KB

From the Filing

VOTING RIGHTS AND CAPITAL a6788j UNITED STATES   SECURITIES AND EXCHANGE COMMISSION   Washington, D.C. 20549     FORM 6-K   REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934   For the month of December 2025   Commission File Number: 001-41411   Haleon plc (Translation of registrant’s name into English)   Building 5, First Floor, The Heights, Weybridge, Surrey, KT13 0NY (Address of principal executive offices)     Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:     Form 20-F ☒   Form 40-F ☐       EXHIBIT INDEX   Exhibit Number   Description   99.1   01 December 2025 - “Total Voting Rights and Capital”       99.1     Haleon plc: Total Voting Rights and Capital   01 December 2025:   As at 30 November 2025 the total number of shares issued by Haleon plc ("Haleon" or the "Company") is   8,952,353,648   ordinary shares of £0.01 each, of which   45,882,158   are held as treasury shares.   Therefore, the number of ordinary shares with voting rights is   8,906,471,490   and this figure should be used by shareholders (and others with notification obligations) as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.   Notifiable interests in Haleon may be sent to:   company.secretary@haleon.com   Amanda Mellor Company Secretary   About Haleon Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as  Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu  and  Voltaren  - are built on trusted science, innovation and deep human understanding.   For more information, please visit   www.haleon.com .            SIGNATURE     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.       HALEON PLC (Registrant)   Date: December 01, 2025 By: /s/ Amanda Mellor     Name: Amanda Mellor     Title: Company Secretary

View Full Filing

View this 6-K filing on SEC EDGAR